Trial record 1 of 4 for:
VIOLET | Prostate Cancer
EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T (VIOLET)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05521412 |
|
Recruitment Status :
Active, not recruiting
First Posted : August 30, 2022
Last Update Posted : March 18, 2024
|
Sponsor:
Peter MacCallum Cancer Centre, Australia
Information provided by (Responsible Party):
Peter MacCallum Cancer Centre, Australia
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | August 3, 2024 |
| Estimated Study Completion Date : | December 2026 |